Taconic Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Taconic Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7560
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company’s products include taconic transgenic mouse models, emerging models, cryopreserved models, traditional models, diet induced obese, traditional models, diet induced obese, Alzheimer disease models, neuropsychiatric disorder models and Parkinson disease models. It offers GEM collection, xenoreceptor panel, cytochrome P450 panel and transporter panel. Taconic offers services such as consultancy, compound administration and tissue extraction. The company also offers monoclonal antibody production, genotyping services, animal health testing, surgical procedures and modifications. It operates offices in the US, Germany and Denmark. Taconic is headquartered in Rensselaer, New York, the US.

Taconic Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taconic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Taconic Biosciences Enters into Agreement with Cergentis 11
Taconic Biosciences Enters into Agreement with Pharmatest 12
Taconic Biosciences Enters into Co-Marketing Agreement with Life Technologies 13
Taconic Biosciences Enters into Agreement with Cellaria Biosciences 14
Taconic Biosciences Expands Distribution Agreement with CLEA Japan 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
Taconic Farms Enters Into Agreement With Medicyte To Promote Upycte Hepatocyte Products 17
Licensing Agreements 18
Taconic Biosciences Enters into Licensing Agreement with University of Nebraska 18
Taconic Enters Into Licensing Agreement With InnoSer 19
Taconic Biosciences Inc – Key Competitors 20
Taconic Biosciences Inc – Key Employees 21
Taconic Biosciences Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Strategy And Business Planning 24
May 03, 2017: Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model 24
Jan 12, 2017: Taconic Biosciences Expands European Immunodeficient Animal Production 25
Corporate Communications 26
Feb 21, 2018: Taconic Biosciences Announces the Formation of Scientific Advisory Board 26
Product News 27
Dec 15, 2017: Protective Efficacy of Influenza Group 2 Hemagglutinin Stem-fragment Immunogen Vaccines 27
Jun 13, 2018: Taconic Biosciences Launches European Production of Diet Induced Obesity Model 28
Apr 25, 2017: Taconic Biosciences Announces Release of New Parkinson’s Disease Animal Model 29
Apr 19, 2018: Taconic Biosciences Launches New Inflammatory Bowel Disease Models 30
Feb 17, 2017: Taconic Biosciences Generates Vici Syndrome Mouse Model 31
Other Significant Developments 32
Sep 20, 2018: Taconic biosciences becomes the first animal model provider on general services administration contract schedule 32
Apr 20, 2018: Taconic Biosciences Launches New Models for Bowel’s Inflammatory Disease 33
May 04, 2017: Taconic Biosciences Expands Microbiome Portfolio 34
Apr 26, 2017: Taconic Biosciences Expands Microbiome Product and Service Platform 35
Apr 03, 2017: Taconic Biosciences Launches ExpressMODEL, a New Accelerated Model Generation Service 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taconic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taconic Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Taconic Biosciences Enters into Agreement with Cergentis 11
Taconic Biosciences Enters into Agreement with Pharmatest 12
Taconic Biosciences Enters into Co-Marketing Agreement with Life Technologies 13
Taconic Biosciences Enters into Agreement with Cellaria Biosciences 14
Taconic Biosciences Expands Distribution Agreement with CLEA Japan 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
Taconic Farms Enters Into Agreement With Medicyte To Promote Upycte Hepatocyte Products 17
Taconic Biosciences Enters into Licensing Agreement with University of Nebraska 18
Taconic Enters Into Licensing Agreement With InnoSer 19
Taconic Biosciences Inc, Key Competitors 20
Taconic Biosciences Inc, Key Employees 21
Taconic Biosciences Inc, Other Locations 22
Taconic Biosciences Inc, Subsidiaries 22

List of Figures
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Taconic Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prestige Brands Holdings Inc (PBH):企業の財務・戦略的SWOT分析
    Prestige Brands Holdings Inc (PBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • CEL-SCI Corp (CVM)-製薬・医療分野:企業M&A・提携分析
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • St. Barbara Limited:企業のM&A・事業提携・投資動向
    St. Barbara Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's St. Barbara Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Sao Martinho SA (SMTO3):企業の財務・戦略的SWOT分析
    Sao Martinho SA (SMTO3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ATLAS Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Co (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on-site …
  • PPL Corporation (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary PPL Corp (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and solar s …
  • Health Dialog Services Corp:企業の戦略的SWOT分析
    Health Dialog Services Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Neuren Pharmaceuticals Ltd (NEU):企業の財務・戦略的SWOT分析
    Summary Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company provides pipeline products such as trofinetide and NNZ-2591. Its trofinetide has a pharmacokinetic profile, which is …
  • Hess Corporation:企業の戦略・SWOT・財務分析
    Hess Corporation - Strategy, SWOT and Corporate Finance Report Summary Hess Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dais Analytic Corps (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …
  • ConocoPhillips (COP):企業の財務・戦略的SWOT分析
    ConocoPhillips (COP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Valora Holding AG (VALN):企業の財務・戦略的SWOT分析
    Valora Holding AG (VALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Adcock Ingram Holdings Ltd (AIP):企業の財務・戦略的SWOT分析
    Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bankinter, S.A.:企業の戦略・SWOT・財務情報
    Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report Summary Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Leprino Foods Co:企業の戦略的SWOT分析
    Leprino Foods Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Madrigal Pharmaceuticals Inc (MDGL):企業の財務・戦略的SWOT分析
    Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aptech Ltd (APTECHT):企業の財務・戦略的SWOT分析
    Aptech Ltd (APTECHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bastide Le Confort Medical SA (BLC)-医療機器分野:企業M&A・提携分析
    Summary Bastide Le Confort Medical SA (Bastide Le) is a medical equipment company that provides personal care products. The company offers medical devices for individuals and home health care professionals. It provides products such as lift chairs and accessories, pillows, cushions and special seati …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆